A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)

LZhang; SLu; JFeng; ADechaphunkul; JChang; DWang; SChessari; CLanzarotti; KJordan; MAapro

首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)

【24h】

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)

机译：评估单剂量NEPA，Netupitant和Palonosetron的固定止吐组合的功效的随机期III研究与预防高均匀化疗（HEC）的患者预防化疗诱导的化疗诱导的恶心和呕吐（CINV）的试剂

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of oncology: official journal of the European Society for Medical Oncology》 |2018年第2期|共7页
作者
LZhang; SLu; JFeng; ADechaphunkul; JChang; DWang; SChessari; CLanzarotti; KJordan; MAapro;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) [J] . LZhang, SLu, JFeng, Annals of oncology: official journal of the European Society for Medical Oncology . 2018,第2期

机译：评估单剂量NEPA，Netupitant和Palonosetron的固定止吐组合的功效的随机期III研究与预防高均匀化疗（HEC）的患者预防化疗诱导的化疗诱导的恶心和呕吐（CINV）的试剂
2. SAFETY AND EFFICACY OF INTRAVENOUS (IV) NEPA, A NOVEL FIXED ANTIEMETIC COMBINATION OF FOSNETUPITANT AND PALONOSETRON, FOR PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) OVER MULTIPLE CYCLES OF HIGHLY EMETOGENIC CHEMOTHERAPY (HEC) [J] . Clark-Snow Rebecca, Koesel Nicole, Rittenberg Cynthia Oncology nursing forum . 2018,第2期

机译：静脉注射（IV）NEPA的安全性和有效性，一种新型固定抗助剂和PalonoSetron的固定止吐组合，用于在高均匀化疗（HEC）的多循环中预防化疗诱导的恶心和呕吐（CINV）
3. A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy [J] . AaproM., RugoH., RossiG., Annals of oncology: official journal of the European Society for Medical Oncology . 2014,第7期

机译：一项随机III期研究，评估NEPA（固定剂量的netupitant和palonosetron组合使用）在中度致呕性化疗后预防化疗引起的恶心和呕吐的有效性和安全性
4. A randomized phase III study evaluating the efficacy of single-dose NEPA a fixed antiemetic combination of netupitant and palonosetron versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) [O] . L Zhang, S Lu, J Feng, -1

机译：一项III期随机研究评估单剂量NEPAnetupitant和palonosetron的固定止吐药与预防性方案在接受高促发性化疗（HEC）的患者中预防化疗引起的恶心和呕吐（CINV）的疗效
5. Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study [O] . Jianhua Chang, Gongyan Chen, Dong Wang, 2020

机译：Nepa的疗效，Netupitant和Palonosetron的固定止吐组合，与在随机相3研究中接受高均匀化疗（HEC）的中国患者中预防化疗诱导的恶性和呕吐（CINV）的3天的抑制剂方案

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)

著录项

相似文献

相关主题

期刊订阅